Medtronic 8-K 2012
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Pursuant to Section 13 OR 15(d) of The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 16, 2012
(Exact name of registrant as specified in its charter)
(Registrants telephone number, including area code)
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
(17 CFR 240.14d-2(b))
(17 CFR 240.13e-4(c))
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 16, 2012, David L. Calhoun notified Medtronic, Inc. (the Company) that he would not stand for reelection to the Board of Directors of the Company at the 2012 annual meeting of shareholders, due to his other board and executive commitments. Mr. Calhouns decision not to pursue reelection was not due to a disagreement with the Company. Mr. Calhoun will continue to serve as a director of the Company until the expiration of his term at the 2012 annual meeting of shareholders.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.